Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 152 resources
-
Summary report: Hepatitis C good practice roadshow, Cambridge
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Cambridge on 9th May 2017. The roadshow was aimed at sharing good practice around hepatitis C and instigating local action to address the virus. The report includes summaries of the talks and workshops held on the day, as well as attendees' pledges for taking further action on hepatitis C.UK, England, East of England Reports & Research PDF -
Global Hepatitis Report 2017
This WHO Global hepatitis report describes the global and regional estimates on viral hepatitis in 2015, setting the baseline for tracking progress in implementing the new global strategy.Rest of World Apr 2017 Reports & Research PDF -
Needle Exchange Surveillance Initiative: 2008-9 to 2015-16
The Needle Exchange Surveillance Initiative measures and monitorings the prevalence of blood-borne viruses and injecting risk behaviours among people who inject drugs in Scotland. This report presents the results, at the NHS board level, for the data collection period from February 2015 until March 2016. It also presents the findings of the NESI survey, at Scotland-wide level, from 2008-09 until the most recent survey, 2015-16.UK, Scotland Mar 2017 Reports & Research PDF -
Evaluation of the South West Hepatitis C Partnership Pilot
An evaluation of a project in which Addaction and The Hepatitis C Trust partnered together to support people with a history of injecting drug use who were engaged with Addaction services into hepatitis C treatment. This report evaluates the success of the pilot's three key interventions:
* Peer education workshops
* A 'buddy' scheme
* Workforce developmentSouth West Reports & Research PDF -
Hepatitis C in England 2017 report
This report by Public Health England has been produced to support monitoring of the recently agreed Global Health Sector Strategy on Viral Hepatitis goals, including the elimination of hepatitis C as a major public health threat by 2030. The report summarises the impact of action plans in England to drive down mortality from hepatitis C, reduce the number of new infections, and outlines the actions required to make further progress.England Mar 2017 Reports & Research, Strategy & Planning PDF -
Hepatitis C in England 2017: Headline table
This table, produced by Public Health England to accompany 'Hepatitis C in England: 2017 report', collates the key statistics and information related to hepatitis C in England, including burden of infection; mortality and morbidity; incidence of infections; adequacy of harm reduction services; diagnosis rates, and the numbers of people accessing treatment.England Mar 2017 Reports & Research PDF -
Summary report: Midlands & East Hepatitis C Educational Event, Nottingham
This report provides a summary of the Midlands & East Hepatitis C Educational Event held by HCV Action and NHS England in Nottingham on Friday 10th February 2017.UK, East Midlands Reports & Research PDF -
Midlands & East Hepatitis C Educational Event in Nottingham: Presentations
On Friday 10th February 2017, HCV Action and NHS England held a Midlands & East Hepatitis C Educational Event in Nottingham. With hepatitis C Operational Delivery Networks (ODNs) still relatively new in operation, the event was held with the aim of offering the chance for ODNs across the Midlands and East region to come together to discuss their experiences, share best practice and develop solutions to some of the challenges they face as they seek to ensure the highest standards of hepatitis C care and treatment.UK, East Midlands Reports & Research MS Powerpoint -
Access and Uptake of Direct Acting Antiviral Medicines in the UK and selected European countries
This report, produced by IMS Health and commissioned by the Association of the British Pharmaceutical Industry (ABPI), provides information related to the uptake of Direct Acting Antiviral treatments (DAAs) over the last five years, to June 2016. The intention of the report is to benchmark the UK – in relation to patient access to these medicines – compared with other European countries. It finds that there have been significant variances in the ability of patients to access these medicines.UK Feb 2017 Reports & Research PDF -
ChemSex and hepatitis C: a guide for healthcare providers
A guide for healthcare providers on those at risk of contracting hepatitis C through ChemSex, featuring key facts, transmission risks, suggestions for engaging with those at risk, terms to be familiar with and a case study.UK Reports & Research, Tools & Templates PDF